HPa2 Monoclonal Antibody Supernatant from Hybridoma DHIC2-2B4 (alpha cell marker)

Case ID:
Web Published:
Technology Overview: The monoclonal antibody HPa2 is derived from the hybridoma DHIC2-2B4.  HPa2 selectively reacts with a cell surface module on human pancreatic endocrine cells. This antibody reacts with multiple endocrine cell types.

Antibody:                             HPa2 Supernatant
Hybridoma cell line:          DHIC2-2B4
Isotype:                                 Mouse IgM
Species reactivity:             Human
Applications:                       Immunohistochemistry (acetone fixation recommended), Flow cytometry

Competitive Environment:  No other such antibodies with such specificity are known to exist.

Patent Status: Patent application filed.

Availability:  1mL supernatant aliquot.

For more information, view the PDF version of this summary: <a href="I:\OHSU\RA\Web\research\rda\trc\docs\1038\1038H_Overview.pdf" target="_blank">HPa2 Antibody Overview</a>
Patent Information:
For Information, Contact:
Trina Voss
Technology Development Manager
Oregon Health & Science University
Philip Streeter
Markus Grompe
Craig Dorrell
Stephanie Abraham
Kelsea Shoop
Biological Materials
Biological Materials - Antibodies
Research Tools
Research Tools - Reagents
© 2022. All Rights Reserved. Powered by Inteum